But abstinence can be a high bar comparable to demanding that an antidepressant produce total remission of despair or that an analgesic absolutely do away with agony. Recognizing this limitation, the FDA encourages developers of opioid2 and stimulant3 use ailment medicines to debate with FDA substitute ways to evaluate improvements in drug use desi